EUVIMEDEUVIMED entdecken
Querschnittstudie

Mucocutaneous manifestations of COVID-19-associated mucormycosis: A retrospective cross-sectional study

Sonal Sachan, Swastika Suvirya, Krishna Yadav, Prashant Gupta, Abir Saraswat, Parul Verma, Usha Chandra, Balendra Pratap Singh, Shyam Chand Chaudhary, Durgesh Kumar Dwivedi, Ravindra Kumar Garg, Atin Singhai und 3 weitere

Indian Journal of Dermatology, Venereology and Leprology · 2022

DOI: 10.25259/ijdvl_277_2022 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Indian Journal of Dermatology, Venereology and Leprology, 2022. Verfasst von Sonal Sachan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprosy, Hind Institute of Medical Sciences, Barabanki, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Mucormycosis, COVID-19, Vascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cutaneous mucormycosis has shown a significant upsurge during the COVID-19 pandemic. Due to the rapid progression and high mortality of cutaneous mucormycosis in this context, it is important to identify it early. However, very few studies report detailed clinical descriptions of cutaneous mucormycosis in COVID-19 patients.

Objectives

To describe mucocutaneous lesions of COVID-19-associated mucormycosis based on clinical morphology and attempt to correlate them with radiological changes.

Methods

A retrospective cross-sectional study was conducted at a tertiary care centre from 1 st April to 31 st July 2021. Eligibility criteria included hospitalised adult patients of COVID-19-associated mucormycosis with mucocutaneous lesions.

Results

All subjects were recently recovering COVID-19 patients diagnosed with cutaneous mucormycosis. One of fifty-three (2%) patients had primary cutaneous mucormycosis, and all of the rest had secondary cutaneous mucormycosis. Secondary cutaneous mucormycosis lesions presented as cutaneous-abscess in 25/52 (48%), nodulo-pustular lesions in 1/52 (2%), necrotic eschar in 1/52 (2%) and ulcero-necrotic in 1/52 (2%). Mucosal lesions were of three broad sub-types: ulcero-necrotic in 1/52 (2%), pustular in 2/52 (4%) and plaques in 1/52 (2%). Twenty out of fifty-two patients (38%) presented with simultaneous mucosal and cutaneous lesions belonging to the above categories. Magnetic resonance imaging of the face showed variable features of cutaneous and subcutaneous tissue involvement, viz. peripherally enhancing collection in the abscess group, “dot in circle sign” and heterogeneous contrast enhancement in the nodulo-pustular group; and fat stranding with infiltration of subcutaneous tissue in cases with necrotic eschar and ulcero-necrotic lesions.

Limitations

The morphological variety of cutaneous mucormycosis patients in a single-centre study like ours might not be very precise. Thus, there is a need to conduct multi-centric prospective studies with larger sample sizes in the future to substantiate our morphological and radiological findings.

Conclusions

COVID-19-associated mucormycosis patients in our study presented with a few specific types of mucocutaneous manifestations, with distinct magnetic resonance imaging findings. If corroborated by larger studies, these observations would be helpful in the early diagnosis of this serious illness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MucormycosisCOVID-19Vascular DiseasesAdultHumansCross-Sectional StudiesProspective StudiesRetrospective StudiesPandemicsAbscessNecrosis

Stichwörter der Autor:innen

COVID-19-associated mucormycosiscutaneous mucormycosis

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Leprosy, Hind Institute of Medical Sciences, Barabanki, Uttar Pradesh, India.
  • Department of Dermatology, Venereology and Leprosy, King George's Medical University, Lucknow, Uttar Pradesh, India.
  • Department of Radiodiagnosis, King George's Medical University, Lucknow, Uttar Pradesh, India.
  • Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, India.
  • Department of Dermatology, Indushree Skin Clinic, Lucknow, Uttar Pradesh, India.
  • Department of Dermatology, Venereology and Leprosy, Lala Lajpat Rai Memorial Medical College, Meerut, Uttar Pradesh, India.

Zitieren

APA

Sachan, S., Suvirya, S., Yadav, K., Gupta, P., Saraswat, A., Verma, P., Chandra, U., Singh, B. P., Chaudhary, S. C., Dwivedi, D. K., Garg, R. K., Singhai, A., Malhotra, K. P., Parihar, A., & Kumar, S. (2022). Mucocutaneous manifestations of COVID-19-associated mucormycosis: A retrospective cross-sectional study. Indian Journal of Dermatology, Venereology and Leprology. https://doi.org/10.25259/ijdvl_277_2022

Vancouver

Sachan S, Suvirya S, Yadav K, Gupta P, Saraswat A, Verma P, et al. Mucocutaneous manifestations of COVID-19-associated mucormycosis: A retrospective cross-sectional study. Indian Journal of Dermatology, Venereology and Leprology. 2022. doi:10.25259/ijdvl_277_2022

BibTeX
@article{Sachan2022,
  author = {Sachan, Sonal and Suvirya, Swastika and Yadav, Krishna and Gupta, Prashant and Saraswat, Abir and Verma, Parul and Chandra, Usha and Singh, Balendra Pratap and Chaudhary, Shyam Chand and Dwivedi, Durgesh Kumar and Garg, Ravindra Kumar and Singhai, Atin and Malhotra, Kiran Preet and Parihar, Anit and Kumar, Saurabh},
  title = {Mucocutaneous manifestations of COVID-19-associated mucormycosis: A retrospective cross-sectional study},
  journal = {Indian Journal of Dermatology, Venereology and Leprology},
  year = {2022},
  doi = {10.25259/ijdvl_277_2022}
}
Kostenlos starten →